ALEXANDRIE, Virginia, December 24 – The Managed Care Journal and Specialty pharmacy, a peer-reviewed journal that claims to strive to engage and serve professionals in pharmacy, medicine, nursing and allied fields to maximize the value of pharmaceuticals and pharmaceutical services provided to patients of Managed Care Pharmacy Academy, has published research articles on the following topics in his January 2022 editing:

To research:

* Trend and effects of high-deductible health insurance plans in the health system: problems of financial access in the management of cognitive disorders

* Biological monitoring to reduce drug-related adverse events: a mixed-method study

* Real-world analysis of churn rate among young adults with schizophrenia using the Colorado All Payors Claims Database

* Coverage of genetic therapies for spinal muscular atrophy in paid Medicaid programs

* Economic impact of the application of the simplified treatment algorithm AASLD-IDSA on the actual management of hepatitis C

* Application of a diazepam milligram equivalence algorithm to assess the intensity of the benzodiazepine dose in Rhode Island in 2018

Research paper :

* US Healthcare Utilization and Costs in Adult Atopic Dermatitis Patients by Disease Severity

* Performance-based risk sharing agreements for devices and diagnostics in United States: a systematic review

* Pharmacists as Accessible Health Care Providers: Quantifying the Opportunity

Outlook on value:

* JAK inhibitors and monoclonal antibodies for the treatment of atopic dermatitis: efficacy and benefit

* The efficacy and value of eculizumab and efgartigimod for generalized myasthenia gravis

the January 2022 edition of the Journal for Managed Care and Specialty Pharmacy can be viewed at https://www.jmcp.org/toc/jmcsp/28/1.